Telix Pharmaceuticals Limited (TLPPF)
USD 17.87
(3.8%)
USD 17.87
(3.8%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.2 Million AUD | -16.28% |
| 2022 | 9.8 Million AUD | 414.16% |
| 2021 | 1.9 Million AUD | 32.43% |
| 2020 | 1.44 Million AUD | -12.25% |
| 2019 | 1.64 Million AUD | 175.2% |
| 2018 | 596.29 Thousand AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 10.06 Million AUD | -20.08% |
| 2024 Q2 | 9.95 Million AUD | 51.69% |
| 2023 Q4 | 8.2 Million AUD | -48.33% |
| 2023 Q1 | 12.25 Million AUD | 24.96% |
| 2023 Q2 | 5.56 Million AUD | -54.55% |
| 2023 Q3 | 15.88 Million AUD | 185.31% |
| 2023 FY | 8.2 Million AUD | -16.28% |
| 2022 Q4 | 9.8 Million AUD | 0.0% |
| 2022 Q2 | 2.01 Million AUD | 0.0% |
| 2022 Q3 | 9.8 Million AUD | 387.57% |
| 2022 Q1 | 2.01 Million AUD | 5.45% |
| 2022 FY | 9.8 Million AUD | 414.16% |
| 2021 Q3 | 1.9 Million AUD | 66.7% |
| 2021 Q4 | 1.9 Million AUD | 0.0% |
| 2021 Q2 | 1.14 Million AUD | 0.0% |
| 2021 Q1 | 1.14 Million AUD | -20.56% |
| 2021 FY | 1.9 Million AUD | 32.43% |
| 2020 Q3 | 1.44 Million AUD | 1033.86% |
| 2020 Q1 | 666 Thousand AUD | -59.41% |
| 2020 Q4 | 1.44 Million AUD | 0.0% |
| 2020 FY | 1.44 Million AUD | -12.25% |
| 2020 Q2 | 127 Thousand AUD | -80.93% |
| 2019 FY | 1.64 Million AUD | 175.2% |
| 2019 Q1 | 676.78 Thousand AUD | 13.5% |
| 2019 Q2 | 390.9 Thousand AUD | -42.24% |
| 2019 Q4 | 1.64 Million AUD | 0.0% |
| 2019 Q3 | 1.64 Million AUD | 319.8% |
| 2018 Q1 | - AUD | 0.0% |
| 2018 FY | 596.29 Thousand AUD | 0.0% |
| 2018 Q4 | 596.29 Thousand AUD | 0.05% |
| 2018 Q3 | 596 Thousand AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bioxytran, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | 60.739% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 8000.00 USD | -102512.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -367.622% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -13898.499% |
| Marizyme, Inc. | 667.12 Thousand USD | -1130.497% |
| Genus plc | 228.2 Million USD | 96.403% |
| Pharming Group N.V. | 166.1 Million USD | 95.058% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -148829.608% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | 2.21 Million USD | -271.448% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -485.131% |
| IMV Inc. | 27.39 Million USD | 70.039% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -51.277% |
| ONE Bio Corp. | 592.19 Thousand USD | -1286.192% |
| RVL Pharmaceuticals plc | 55.61 Million USD | 85.239% |
| Mesoblast Limited | 100.29 Million USD | 91.815% |
| MultiCell Technologies, Inc. | 36.43 USD | -22533526.132% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -268.778% |
| Genscript Biotech Corporation | 287.12 Million USD | 97.141% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -568.289% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| Biomind Labs Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -32347.923% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -332.401% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -4694.137% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -2449.379% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 99.927% |
| Agentix Corp. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -1380.193% |
| Enzolytics Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -4899.239% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | 46.535% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | 59.585% |
| HST Global, Inc. | - USD | -Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 150 Thousand USD | -5372.667% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -184123.519% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -6399.501% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -3480.167% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | 0.666% |
| Kadimastem Ltd | 229.69 Thousand USD | -3473.932% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -2990.331% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 1064.00 USD | -771422.556% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -5386.786% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -5386.786% |
| Affymax, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| International Stem Cell Corporation | 445 Thousand USD | -1744.719% |
| CytoDyn Inc. | 141 Thousand USD | -5721.986% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -10161.25% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -4.975% |
| SYBLEU INC | 300 Thousand USD | -2636.333% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -2124.366% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -0.724% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -1696.28% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -607.063% |
| PureTech Health plc | 18.25 Million USD | 55.019% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -5372.667% |
| IXICO plc | 275 Thousand USD | -2885.091% |
| IntelGenx Technologies Corp. | 11.83 Million USD | 30.661% |
| Gelesis Holdings, Inc. | 26.3 Million USD | 68.798% |
| CSL Limited | 11.23 Billion USD | 99.927% |
| Cellectis S.A. | 36.21 Million USD | 77.33% |